Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Mass drug administration for lymphatic filariasis elimination amidst COVID-19 pandemic in Odisha, India: A step towards achieving SDG-3

Sinha A, Mohapatra S, Mohanty S, et al. SAGE Publications. Tropical Doctor. 2022;
Download PDF
Publication

Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India.

Sabesan S, Krishnamoorthy K, Hoti S, et al. The Indian journal of medical research. 2022;
Publication

Validation of a Culturally Relevant Snakebite Envenomation Clinical Practice Guideline in Brazil.

Rocha G, Farias A, Alcântara J, et al. Toxins. 2022;
Download PDF
Publication

Scaling up of tsetse control to eliminate Gambian sleeping sickness in northern Uganda.

Hope A, Mugenyi A, Esterhuizen J, et al. PLoS neglected tropical diseases. 2022; 16 (6) : e0010222.
Download PDF
Publication

A Contemporary Exploration of Traditional Indian Snake Envenomation Therapies

Deshpande AM, Sastry KV, Bhise SB. MDPI AG. Tropical Medicine and Infectious Disease. 2022; 7 (6) : 108.
Download PDF
Publication

Total prevention: a history of schistosomiasis in Japan

Bay AR. Cambridge University Press (CUP). Medical History. 2022; 66 (2) : 95-115.
Download PDF
Publication

Urogenital schistosomiasis prevalence, knowledge, practices and compliance to MDA among school-age children in an endemic district, southern East Tanzania

Nazareth LC, Lupenza ET, Zacharia A, et al. Elsevier BV. Parasite Epidemiology and Control. 2022;
Download PDF
Publication

The WHO new guideline to control and eliminate human schistosomiasis: implications for the verification of transmission interruption and surveillance of Schistosoma japonicum in China

Xu J, Li S, Guo J, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2022;
Download PDF
Publication

Environmental impacts of mass drug administration programs: exposures, risks, and mitigation of antimicrobial resistance

Konopka JK, Chatterjee P, LaMontagne C, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2022;
Download PDF
Publication

Mapping of schistosomiasis and soil-transmitted helminthiases across 15 provinces of Angola

Mendes EP, Okhai H, Cristóvão RE, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (6) : e0010458.
Download PDF

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 317
  • Page 318
  • Page 319
  • Page 320
  • Current page 321
  • Page 322
  • Page 323
  • Page 324
  • Page 325
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD